Skip to content
healthcare.dev

Renvela

NDC 58468-0133, SEVELAMER CARBONATE, tablet, film coated, from Genzyme Corporation.

Product NDC
58468-0133
Status
Listed
Labeler
Genzyme Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022127
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0133 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SEVELAMER CARBONATE800 mg/1

Pharmacologic classes

Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

Package NDCNDC-11Package
58468-0133-158468013301270 TABLET, FILM COATED in 1 BOTTLE (58468-0133-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e6328460-a57b-450b-a48c-6dcd4b476360
  • NADAC price for package 58468013301

    GET /v1/drugs/nadac/58468013301

Use it

Look up 58468-0133 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0133 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.